EGFR and non-small cell lung carcinoma: Cobas® EGFR Mutation Test v2 is a CE-IVD marked method for detecting EGFR mutations in NSCLC patients with a LOD of 100 mutant copies/mL of plasma for EGFR-Thr790Met mutation.